Clinical Trial Update: Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance [NA]

View source ↗

Summary

Clinical trial evaluating tauroursodeoxycholic acid for insulin resistance related to HIV protease inhibitors; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Related Insulin Resistance
• Protease Inhibitor Related Insulin Resistance

Drugs mentioned

• Tauroursodeoxycholic acid (tauroursodeoxycholic acid)

Snippet

Sponsor: Washington University School of Medicine | Conditions: HIV Related Insulin Resistance, Protease Inhibitor Related Insulin Resistance | NA | Status: COMPLETED | Results posted: 2020-01-27